Sara Carazo
Centre hospitalier universitaire de Québec(CA)Centre hospitalier universitaire de Québec(CA)Institut National de Santé Publique du Québec(CA)Institut National de Santé Publique du Québec(CA)Institut National de Santé Publique(CI)Centre hospitalier de l'Université Laval(CA)Université Laval(CA)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, COVID-19 Clinical Research Studies, Vaccine Coverage and Hesitancy, Respiratory viral infections research
Most-Cited Works
- → Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea(2016)482 cited
- → Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted(2017)186 cited
- → Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study(2022)121 cited
- → 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)(2024)68 cited
- → Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada(2022)53 cited